Compare IDAI & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDAI | NXPL |
|---|---|---|
| Founded | 2016 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Telecommunications Equipment |
| Sector | Technology | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 19.2M |
| IPO Year | N/A | N/A |
| Metric | IDAI | NXPL |
|---|---|---|
| Price | $3.89 | $0.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 93.7K | 77.3K |
| Earning Date | 11-14-2025 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,727,824.00 | ★ $57,151,000.00 |
| Revenue This Year | $3.46 | N/A |
| Revenue Next Year | $219.85 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 72.57 | N/A |
| 52 Week Low | $1.43 | $0.43 |
| 52 Week High | $5.28 | $1.13 |
| Indicator | IDAI | NXPL |
|---|---|---|
| Relative Strength Index (RSI) | 46.63 | 55.79 |
| Support Level | $3.80 | $0.68 |
| Resistance Level | $4.31 | $0.72 |
| Average True Range (ATR) | 0.29 | 0.04 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 17.54 | 71.90 |
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.